Friday 11th - Monday 14th December, 2020
Head to Toe
Virtual
The HTT has been well established for a number of years and we are pleased to offer the 2020 meeting in a new virtual format. Similar to previous years, the meeting will cover a breadth of pathologies suitable for both residents and radiologists.
Outcomes of Cardiovascular MRI in patients recently recovered from COVID-19*
E. Nagel
CTPA - How we do it to achieve consistent image quality, practical review of the protocol, image interpretation and interesting cases from the Charité
F. Döllinger & D. Günther
MRI screening in women with dense breast – what do patients gain?*
J. Camps-Herrero, C. Kuhl, R. Mann
Digital Solutions from Bayer- new perspectives on the horizon
A. Salvador, G. Mathews
(These sessions will be recorded and made available to view on-demand during the rest of the event)
Present and future direction in CNS imaging
N. Anzalone, H. Pietsch
Additional MRI screening in women with extremely dense breasts*
C. van Gils
Breast MR abbreviated protocols*
C. Kuhl
Gd-EOB-DTPA-liver specific contrast agents in liver metastases
L. Grazioli, R. Faletti
How the choice of MR contrast agent influences the management of patients with liver diseases
G. Brancatelli, M. Karcaaltincaba
The role of IDR and injector technology in CT coronary angiography
F. Bamberg, M. Rengo,
C. Kemper, M. McDermott
Renal Safety and Iodinated Contrast Media
P. Persson, J. Wildberger,
Z. Jin
Further understanding CTCME hypersensitivity reactions
W. Lee, J. Endrikat, L. Bin
Imaging in COVID-19: The Charité Berlin experience
F. Döllinger
We also offer the opportunity to browse behind the scenes at Bayer HQ. Hosted by Hubertus Pietsch (Head of Contrast Media R&D) we will share some insights into the work of the research team. Further to this, you can also learn more about our existing portfolio of marketed products with our virtual reality experience.
Disclaimer:
This virtual conference site is not under the responsibility of Bayer (Schweiz) AG. It might contain information that is not in line with Swi$ marketing authorizations of Bayer products. Therefore, before prescribing any product, always refer to local materials such as the professional information available on www.swissmedicinfo.ch
The medical Information, scientific topics and product(s) data presented in this event (Live webinars and recordings ) is provided for self-learning & medical education purpose - represents the speaker(s) view with no responsibility on Bayer for any content misinterpretation or mentioned products’ off label data that is/are not approved in your country product label and local country health authority regulations.